Open clinical trial on the sigma ligand panamesine in patients with schizophrenia

Psychopharmacology

Volumn 132, Issue 1, 1997, Pages 82-88

  Frieboes, Ralf Michael ^a   Murck, Harald ^a   Wiedemann, Klaus ^a   Holsboer, Florian ^a   Steiger, Axel ^a  

^a MAX PLANCK INSTITUTE OF PSYCHIATRY   (Germany)

Author keywords

Atypical antipsychotic drug; Extrapyramidal symptoms; Panamesine; Schizophrenia; Sigma ligand

Indexed keywords

DOPAMINE 2 RECEPTOR BLOCKING AGENT; DRUG METABOLITE; LORAZEPAM; PANAMESINE; PROLACTIN; SIGMA RECEPTOR LIGAND; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG SAFETY; EXTRAPYRAMIDAL SYMPTOM; FEMALE; HEADACHE; HUMAN; HYPERPROLACTINEMIA; MALE; PRIORITY JOURNAL; PROLACTIN BLOOD LEVEL; PSYCHOMETRY; RATING SCALE; SCHIZOPHRENIA; VERTIGO;

ACUTE DISEASE; ADOLESCENT; ADULT; ANTIPSYCHOTIC AGENTS; BRIEF PSYCHIATRIC RATING SCALE; FEMALE; HUMANS; MALE; OXAZOLES; PIPERIDINES; PROLACTIN; RECEPTORS, SIGMA; SCHIZOPHRENIA; SLEEP;

EID: 0030738237     PISSN: 00333158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002130050323     Document Type: Article

References (36)

1. Allen RM, Young SJ (1978) Phencyclidine-induced psychosis. Am J Psychiatry 135 : 1081-1084
2. Barnes TRE (1989) A ratine scale for drug-induced akathisia. Br J Psychiatry 154 : 672
3. Bartoszyk GD, Bender HM, Hellmann J, Schnorr C, Seyfried CA (1996) EMD 57445: a selective sigma receptor ligand with the profile of an atypical neuroleptic. CNS Drug Rev 2 : 175-194
4. Brady KT, Balster RL, May FL (1982) Steroisomers of N-allyl-normetazocine: phenylcyclidine-like behavioral effects in squirrel monkeys and rats. Science 215 : 178-180
5. Bunney BG, Bunney WE, Carlsson A (1995) Schizophrenia and glutamate. In: Bloom FE, Kupfer DJ (eds) Psychopharmacology: the fourth generation of progress. Raven Press. New York, pp 1205-1214
6. Chouinard G, Ross-Chouinard A, Annable L, Jones BD (1980) The extrapyramidal symptom rating scale. Can J Neurol Sci 7 : 233
7. Debonnel G (1993) Current hypotheses on sigma receptors and their physiological role: possible implications in psychiatry. J Psychiatr Neurosci 18 : 157-172
8. Gewirtz GR, Gorman JM, Volavka J, Macaluso J, Gribkoff G, Taylor DP, Borison R (1994) BMY 14802. a sigma receptor ligand for the treatment of schizophrenia. Neuropsychopharmacology 10 : 37-40
9. Grunze HC, Rainnie DG, Hasselmo ME, Barkai E, Hearn EF, McCarley RW, Greene RW (1996) NMDA-dependent modulation of CA1 local circuit inhibition. J Neurosci 16 : 2034-2043
10. Guy W (ed) (1976) Clinical Global Impressions CGI. In: Guy W (ed) ECDEU assessment manual for psychopharmacology. revised. Rockville. Maryland
11. Haertzen CA (1970) Subjective effects of narcotic antagonists cyclozacine and nalorphine on the addiction research center inventory. Psychopharmacologia 18 : 366-377
12. Hirsch SR, Barnes TRE (1990) Testing the efficacy of new neuroleptic drugs. In: Benkert O, Maier W, Rickels K (eds) Methodology of the evaluation of psychotropic drugs (Psychopharmacology series, vol 8). Springer, Berlin Heidelberg New York, pp 26-36
13. Itzhak Y, Alerhand S (1989) Differential regulation of sigma and PCP receptors after chronic administration of haloperidol and phencyclidine in mice. FASEB J 3 : 1868-1872
14. Kay SR, Opler LA, Fiszbein A (1992) Positive and negative syndrome scale (PANSS). Rating, Manual. Multi Health Systems, Toronto
15. Kinon BJ, Eieberman JA (1996) Mechanisms of action of atypical antipsychotic drugs: a critical analysis. Psychopharmacology 124 : 2-34
16. Klein DF (1991) Improvement of phase III psychotropic drug trials by intensive phase II work. Neuropsychopharmacology 4 : 251-258
17. Lauer CJ, Schreiber W, Pollmächer T, Holsboer F, Krieg JC (1997) Sleep in schizophrenia: a polysomnographic study on drug naive patients. Neuropsychopharmacology 16 : 51-60
18. Martin WR, Eades CG, Thompson JA, Huppler RE, Gilbert PE (1976) The effects of morphine- and nalorphine-like drugs in the nondependent and morphine-dependent chronic spinal dog. J Pharmacol Exp Ther 197 : 517-532
19. Mash DC, Zabetian CP (1992) Sigma receptors are associated with cortical limbic areas in the primate brain. Synapse 12 : 195-205
20. Meltzer HY (1995) Atypical antipsychotic drugs. In: Bloom FE, Kupfer DJ (eds) Psychopharmacology: the fourth generation of progress. Raven Press, New York, pp 1277-1286
21. Modell S, Naber D, Holzbach R (1996) Efficacy and safety of an opiate sigma-receptor antagonist (SL 82.0715) in schizophrenic patients with negative symptoms: an open dose-range study. Pharmacopsychiatry 29 : 63-66
22. Ogawa S, Okuyama S, Araki H, Otomo S (1994) Effect of NE-100, a novel σ receptor ligand. on phencyclidine-induced cognitive dysfunction. Eur J Pharmacol 263 : 9-15
23. Okuyama S, Imagawa S, Ogawa H (1993) NE-100, a novel sigma receptor ligand: in vivo tests. Life Sci 53 : 285
24. Overall JE, Gorham DR (1976) Brief Psychiatric Rating Scale. In: Guy W (ed) ECDEU assessment manual for psychopharmacology, revised. Rockville, Maryland
25. Quirion R, Chicheportiche R, Contreras P, Johnson K, Lodge D, Tam S, Woods J, Zukin S (1987) Classification and nomenclature of phencyclidine and sigma receptor sites. Trends Neurosci 10 : 444-446
26. Quirion R, Bowen WD, Itzhak Y, Junien JL, Musacchio JM, Rothman RB, Su TP, Tam W, Tayler DP (1992) A proposal for the classification of sigma binding sites. Trends Pharmacol Sci 13 : 85-86
27. Rechtschaffen A, Kales A (1968) A manual of standardized terminology, techniques and scoring system for sleep stages of human subjects. US Department of Health, Education & Welfare, Bethesda
28. 3H]Ditolyl-guanidine binding to human brain sites is diminished after haloperidol treatment. Eur J Pharmacol 194 : 235-236
29. Rückert NG, Schmidt WJ (1993) The σ receptor ligand 1,3-di-(2-tolyl)guanidine in animal models of schizophrenia. Eur J Pharmacol 233 : 261-267
30. Schuster DI, Arnold FJ, Murphy RB (1995) Purification, pharmacological characterization and photoaffinity labeling of sigma receptors from rat and bovine brain. Brain Res 670 : 14-28
31. Sharkey J, Glen K, Wolfe S, Kuhar MJ (1988) Cocaine binding at sigma receptors. Eur J Pharmacol 149 : 171-174
32. 3H]haloperidol binding in guinea pig brain membranes. Proc Natl Acad Sci USA 81 : 5618-5621
33. 3H]tolyl) guanidine: a selective ligand that labels σ-type receptors for psychotomimetic opiates and antipsychotic drugs. Proc Natl Acad Sci USA 83 : 8784-8788
34. Weiner I, Traub A, Rawlins J, Smith A, Feldon J (1995) The sigma ligand BMY-14802 as a potential antipsychotic: evidence from the latent inhibition model in rats. Behav Pharmacol 6 : 46-54
35. Weissman AD, Casanova MF, Kleinman JE, London ED, De Souza EB (1991) Selective loss of cerebral cortical sigma, but not PCP binding sites in schizophrenia. Biol Psychiatry 29 : 41-54
36. Wetter TC, Lauer CJ, Gillich G, Pollmächer T (1996) The electroencephalographic sleep pattern in schizophrenic patients treated with clozapine or classical antipsychotic drugs. J Psychiatr Res 30 : 411-419